Durability of sustained virologic response in patients with chronic hepatitis C after treatment with interferon α-2b alone or in combination with ribavirin.

被引：0
|
作者：
McHutchison, JG
Davis, GL
Esteban-Mur, R
Poynard, T
Ling, MH
Garaud, JJ
Albrecht, J
机构：
[1] Scripps Clin, La Jolla, CA USA
[2] Univ Florida, Coll Med, Gainesville, FL USA
[3] Hosp Gen Valle Hebron, Barcelona, Spain
[4] Grp Hosp Pitie Salpetriere, F-75634 Paris, France
[5] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
281
引用
收藏
页码：244A / 244A
页数：1
相关论文
共 50 条
  • [41] Interferon alone or in combination with ribavirin for the treatment of chronic hepatitis C genotype IV
    Shiha, G
    Salem, S
    JOURNAL OF HEPATOLOGY, 2002, 36 : 129 - 129
  • [42] Treatment of chronic hepatitis C virus infection with α-interferon alone or in combination with ribavirin
    Marra, F
    Yoshida, EM
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1999, 8 (09) : 429 - 438
  • [43] Rheumatic manifestations in children with chronic C virus hepatitis treated with interferon-α 2b plus ribavirin.
    Molano, A
    Gorbea, MD
    Fuentes, J
    Fraga, A
    Medina, F
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S191 - S191
  • [44] Hepatic steatosis is a predictor of poor response to interferon α-2b and ribavirin combination therapy in Japanese patients with chronic hepatitis C
    Yaginuma, Reiko
    Ikejima, Kenichi
    Okumura, Kyoko
    Kon, Kazuyoshi
    Suzuki, Satoko
    Takei, Yoshiyuki
    Sato, Nobuhiro
    HEPATOLOGY RESEARCH, 2006, 35 (01) : 19 - 25
  • [45] Hispanic patients with genotype 2 or 3 chronic hepatitis C have lower rates of sustained virologic response to treatment with pegylated interferon and ribavirin
    Douglass, Jeff
    Qualls, Clifford
    Wiggins, Charles
    Dunkelberg, Jeff
    Arora, Sanjeev
    GASTROENTEROLOGY, 2006, 130 (04) : A770 - A770
  • [46] Rapid Virologic Response Predicts Sustained Virologic Response in Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin Therapy
    Sarwar, Shahzad
    Iqbal, Masood
    McCormick, P. Aiden
    O'Farrelly, Cliona
    Hegarty, John E.
    GASTROENTEROLOGY, 2009, 136 (05) : A836 - A837
  • [47] Predictors of virologic response in combination therapy with interferon (IFN) alfa 2B plus ribavirin of recurrent hepatitis C after liver transplantation (LT)
    Lavezzo, B
    Franchello, A
    Smedile, A
    Cocchis, D
    David, E
    Barbui, A
    Ottobrelli, A
    Fadda, M
    Brunati, A
    Salizzoni, M
    Rizzetto, M
    JOURNAL OF HEPATOLOGY, 2003, 38 : 5 - 5
  • [48] Lower levels of adherence to therapy influence sustained response rates in chronic hepatitis C patients receiving peginterferon alfa 2b plus ribavirin.
    McHutchison, JG
    Patel, K
    Manns, MP
    Poynard, T
    Dienstag, JL
    Albrecht, JK
    HEPATOLOGY, 2002, 36 (04) : 287A - 287A
  • [49] Ribavirin and interferon-α-2b combination treatment of chronic hepatitis C in patients with haemophilia and other clotting disorders.
    Fried, R
    Meili, E
    Peter, K
    Hartmann, S
    Tsakiris, D
    Fried, C
    Egger, H
    Zanni, M
    Marbet, G
    GASTROENTEROLOGY, 1999, 116 (04) : A1212 - A1212
  • [50] Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C
    de Lédinghen, V
    Trimoulet, P
    Winnock, M
    Foucher, J
    Bourlière, M
    Desmorat, H
    Canva, V
    Capron, D
    Lévy, S
    Mion, F
    Mannant, PR
    Chêne, G
    Fleury, H
    Couzigou, P
    Bernard, PH
    JOURNAL OF HEPATOLOGY, 2002, 36 (05) : 672 - 680
12345